Home > Polymers & Advanced Materials > Parenteral Packaging Market

Parenteral Packaging Market Size By Packaging (Vials, Cartridges, Ampoules, Prefilled Syringes, Infusion Solutions Bottles, Infusion Solutions Bags, Containers, Others), By Material (Glass, Polymers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Landscape & Forecast, 2023 – 2032

  • Report ID: GMI5389
  • Published Date: Oct 2022
  • Report Format: PDF

Industry Overview

Parenteral Packaging Market size value was over USD 30 billion in 2022. Given the increased requirement for medical treatments among the growing geriatric population, the industry is poised to depict more than 6% CAGR through 2023-2032.

Get more details on this report - Request Free Sample PDF

The number of elderly people continues to grow worldwide. In European countries, the average life expectancy was over 75 years in 2010 and is expected to rise to over 80 years through the next decade, which can be credited to the advancement in medical practices. The need for the diagnosis and management of geriatric medical problems will therefore rise, augmenting the demand for cartridges, ampoules, and other parenteral products.

With the surge in the requirement for medical treatment among the elderly population, the packaging of parenteral products is gaining popularity. These products are considered highly sensitive in terms of packaging, handling, storage, and transportation. Moreover, the increasing incidence of diabetes in obese people due to the adoption of unhealthy lifestyles has been growing. As per the CDC, obesity prevalence was 41.9% between 2017 and March 2020 in the U.S. Factors such as these will proliferate the use of cartridges in insulin pumps for these diabetic patients and promote the use of parenteral packaging.

Supply and demand variations due to fluctuating costs of raw materials such as polymers and glass are, however, impacting the sales of parenteral package solutions globally. In addition, downward pressure on prices amid strong competition from multinational manufacturers is creating a hindrance to industry expansion. Despite these challenges, the mounting usage of injectable pharmaceuticals may lead to a recovery in cartridge production, fueling parenteral packaging industry growth over the estimated timeline.

Advancements in the pharmaceutical products to augment demand for vial packaging materials

Get more details on this report - Request Free Sample PDF

In terms of packaging, parenteral packaging market value from the vials segment is anticipated to be worth over USD 6 billion by 2032. In the healthcare industry, vials are utilized to keep medications in liquid form and hold powders and tablets. The adoption of this parenteral packaging solution for the transportation of medication dosages is thus increasing, as a result of the rapid pharma sector development. Furthermore, the growing burden of diseases that require therapeutic approaches will boost the consumption of vial parenteral packaging.

Use of glass garners momentum as preferred material for parenteral packaging applications

Get more details on this report - Request Free Sample PDF

Based on material, the parenteral packaging market is categorized into glass and polymers. The market share from the glass segment is poised to depict a 7% CAGR through 2023-2032. Glass is extensively used in the manufacturing of cartridges, vials, prefilled syringes, ampoules, and other products. It is emerging as a major raw material for parenteral packaging applications, owing to its non-porous and impermeable nature, product composition maintenance, UV protection, and enhanced shelf life. In addition, the growing consumption of generic injectable drugs will accelerate the production of glass parenteral packaging products over the forthcoming years.

Asia Pacific to emerge as a lucrative revenue pocket for parenteral packaging manufacturers

Get more details on this report - Request Free Sample PDF

Asia Pacific parenteral packaging market size is projected to reach over USD 27.5 billion by 2032. The rising emphasis on the creation of sustainable and biodegradable packaging solutions and the advancement in manufacturing processes are among the key growth drivers. Over the years, there has been an increase in investments in R&D projects to innovate packaging technologies. Initiatives such as these will stimulate the development of efficient parenteral packaging materials in the region. APAC is also home to some of the biggest healthcare markets in the world, indicating the significant potential for the industry.

Manufacturing capacity expansion by major players to strengthen the industry outlook

Becton, Dickinson and Company (BD), Schott AG, Gerresheimer AG, Nipro Corporation, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Baxter International Inc., Terumo Corporation, Stevanato Group S.p.A., Corning Inc., Catalent, Inc., and Sio2 Materials Science are some of the prominent players in the parenteral packaging market. These firms are focusing on strategies such as manufacturing capacity expansion to boost their customer base and reinforce their presence in the market.

Impact of COVID-19 outbreak on parenteral packaging market trends

Immunization and vaccination became essential health activities during the COVID-19 pandemic. Since vaccinations against potential variants of the virus have become a top priority, the sales of vials and glass tubes have soared, especially in the U.S. and Europe markets. The introduction of immunization campaigns has also encouraged ampoules producers to operate at breakneck rates to address the burgeoning vaccine demand. The escalating consumption of sterilized glass syringes for bio-pharma drugs will thus support parenteral packaging material developers, even in the post-pandemic era.

The parenteral packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in kilo tons and revenue in USD million from 2018 to 2032 for the following segments:

By Packaging Type

  • Vials
  • Cartridges
  • Ampoules
  • Prefilled syringes
  • Infusion solutions bottles
  • Infusion solutions bags
  • Containers
  • Others

By Material

  • Glass
  • Polymers

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
Authors: Kiran Pulidindi , Hiralkumar Patel

Frequently Asked Questions (FAQ) :

The market size for parenteral packaging reached over USD 30 billion in 2022 and is poised to exhibit more than a 6% CAGR through 2023-2032, due to the rising number of geriatric people susceptible to medical conditions.
Parenteral packaging industry share from the glass material segment is poised to depict a 7% CAGR through 2023-2032, owing to UV protection, enhanced shelf life, non-porous nature, and other advantages.
APAC parenteral packaging industry size is projected to reach over USD 27.5 billion by 2032, given the high emphasis on the development of sustainable and biodegradable packaging solutions.
Key players in the parenteral packaging industry include Schott AG, Gerresheimer AG, Nipro Corporation, Ypsomed Holding AG, Baxter International Inc., Terumo Corporation, Catalent, Inc., and Sio2 Materials Science, among others.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 297
  • Countries covered: 20
  • Pages: 275
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount